You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 21 - 30 of 30 results
 
  • Record 1 TO 30

  1. Endogenous Retrovirus Herv-K in Lymphoma and ALS

    SBC: SLIL BIOMEDICAL CORPORATION            Topic: N/A

    DESCRIPTION (provided by investigator): Retroviruses have long been associated with both hematological malignancies and neurological disorders in humans. Infection with the retrovirus HTLV-1 can lead either to the development of adult T cell leukemia (ATL) or HTLV-1 associated myelopathy. Infection with HIV is associated with the development of Non- Hodgkin's lymphoma (NHL) and the development of ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  2. Therapeutic Antimicrobial Human Skin Substitute

    SBC: Stratatech Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The ultimate goal of our proposal is to genetically engineer a therapeutic human skin substitute for use in the treatment of skin lesions such as skin wounds (e.g., pathological or traumatic) and ulcers (e.g., venous and diabetic ulcers). Chronic skin ulcers are particularly problematic as they typically become infected resulting in impaired wound healing an ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  3. Efficacy of Liposomal Budesonide in Experimental Asthma

    SBC: VGSK, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Asthma is the most common chronic illness in childhood and affects 5 to 10% of the population. The disease is characterized by acute bronchoconstriction, chronic inflammation, and airway remodeling which may lead to progressive, irreversible lung damage. Current asthma therapy is directed at reducing the lung inflammation with the use of anti-inflammatory drugs ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  4. N/A

    SBC: Epicentre Technologies Corporation            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  5. N/A

    SBC: METABIOLOGICS, INC.            Topic: N/A

    N/A

    STTR Phase II 2000 Department of DefenseArmy

  6. N/A

    SBC: Midwest R.F., LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  7. N/A

    SBC: Nomadics, Inc.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of DefenseAir Force

  8. N/A

    SBC: Nomadics, Inc.            Topic: N/A

    N/A

    STTR Phase II 2000 Department of DefenseAir Force

  9. N/A

    SBC: Nomadics, Inc.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of DefenseNavy

  10. N/A

    SBC: OCEANIT LABORATORIES INC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of DefenseAir Force
US Flag An Official Website of the United States Government